Medical device market entry is one of the most regulated and commercially complex challenges in the healthcare sector – requiring simultaneous navigation of regulatory clearance pathways, tender processes, clinical evaluation requirements, distributor selection, and hospital procurement cycles. GreyRadius helps medical device companies validate new markets, navigate regulatory requirements, identify distributors, execute GTM plans, and raise capital – grounded in primary research with clinicians, procurement officers, and regulatory authorities.
Why now? Healthcare infrastructure investment across Southeast Asia, South Asia, and the Gulf is at a multi-decade high – driven by government hospital construction programmes, national health insurance expansion, and post-pandemic healthcare system strengthening. Medical device procurement budgets are growing in line with this investment.
Medical device market in Southeast Asia is growing at 8% annually – driven by hospital construction, national health insurance expansion, and increasing prevalence of chronic diseases requiring device-based treatment.
Localisation requirements for medical device manufacturing are intensifying – India's Medical Devices Park scheme, Indonesia's domestic preference policies, and Gulf localisation programmes are all creating incentives for local manufacturing investment.
Digital diagnostics and AI-enabled medical devices are gaining regulatory approval – FDA, CE, and Asian regulatory bodies are establishing pathways for AI medical devices, creating commercial deployment opportunities.
Tender processes are the primary sales channel for hospital medical devices in emerging markets – government hospital procurement is concentrated in large tenders that require years of relationship building and product registration.
If you recognise your situation below, we can help.
Regulatory clearance pathway
You need to understand medical device registration processes, clinical evaluation requirements, and timeline for regulatory approval in your target market.
Hospital procurement and tender processes
You need to understand how hospitals and government health systems procure medical devices including tender procedures and evaluation criteria.
Distributor identification and selection
You need to identify, evaluate, and select the right distribution partners in your target market covering market coverage and clinical support capability.
Clinical champion development
You need to identify key opinion leaders and clinical champions who can validate your device and support adoption across hospital networks.
Raising capital for a MedTech venture
You are raising investment and need a pitch book grounded in clinical evidence, market sizing, and regulatory pathway clarity.
Medical device competitive intelligence
You need to understand how competing devices are positioned, priced, and distributed in your target clinical segment.
Every engagement is grounded in primary research and delivers a measurable outcome.
Validate clinical demand and market opportunity for your medical device in a new market. Covers clinician interviews, procurement committee research, regulatory mapping, and a Go/Defer/Kill recommendation.
Learn more →Full financial and operational feasibility for medical device market entry. Covers demand modelling, distributor economics, regulatory cost pathway, revenue model, and financial projections.
Learn more →End-to-end market entry for medical device companies. Regulatory pathway, distributor identification and selection, clinical champion development, and first-hospital or first-tender acquisition.
Learn more →Embedded GTM team for medical device companies. Hospital outreach, clinical champion engagement, distributor pipeline management, and first-revenue milestone tracking.
Learn more →Investor-ready pitch books for MedTech ventures. Clinical demand-validated market sizing, regulatory pathway clarity, financial model, and investor identification.
Learn more →AI use-case prioritisation in medical devices – from predictive maintenance and connected device monitoring to clinical decision support integration and automated compliance.
Learn more →80% of our insight comes from first-party interviews with buyers, competitors, and regulators – not secondary data that everyone else has.
Our AI layer compresses research timelines by 60% and surfaces pattern-matching from 200+ prior mandates – so you get faster, deeper answers.
We measure success by first contracts signed, capital raised, and markets entered – not deliverables produced. Every mandate has a milestone.
200+
Projects delivered
100+
SaaS & tech clients
80%
Primary research-led
4
Countries / offices
Healthcare · Market Entry
Healthcare · GTM Execution
Healthcare · Assessment
Both. We work with established manufacturers on new market entry and with MedTech startups on market entry, GTM, and fundraising.
Southeast Asia, South Asia, and the Gulf – markets with active hospital infrastructure investment and growing medical device demand.
Typically 8–12 weeks given the complexity of regulatory pathway mapping and clinical stakeholder research.
Yes. Distributor identification, evaluation, and initial commercial conversations are part of our market entry execution service for medical device companies.
GreyRadius research notes, market entry signals, and sector briefs – delivered weekly. No fluff.
Not sure which engagement fits? Take our free 2-minute diagnostic →
Primary research. AI-enabled analysis, expert-reviewed. Outcomes-based delivery – across Southeast Asia, South Asia, Gulf.
